1. Home
  2. ASRT vs ACOG Comparison

ASRT vs ACOG Comparison

Compare ASRT & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • ACOG
  • Stock Information
  • Founded
  • ASRT 1995
  • ACOG 2000
  • Country
  • ASRT United States
  • ACOG Canada
  • Employees
  • ASRT N/A
  • ACOG N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • ACOG
  • Sector
  • ASRT Health Care
  • ACOG
  • Exchange
  • ASRT Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • ASRT 78.3M
  • ACOG 91.6M
  • IPO Year
  • ASRT 1997
  • ACOG N/A
  • Fundamental
  • Price
  • ASRT $0.84
  • ACOG $6.03
  • Analyst Decision
  • ASRT Strong Buy
  • ACOG
  • Analyst Count
  • ASRT 4
  • ACOG 0
  • Target Price
  • ASRT $3.19
  • ACOG N/A
  • AVG Volume (30 Days)
  • ASRT 341.2K
  • ACOG 103.6K
  • Earning Date
  • ASRT 03-10-2025
  • ACOG 11-15-2024
  • Dividend Yield
  • ASRT N/A
  • ACOG N/A
  • EPS Growth
  • ASRT N/A
  • ACOG N/A
  • EPS
  • ASRT N/A
  • ACOG N/A
  • Revenue
  • ASRT $125,763,000.00
  • ACOG N/A
  • Revenue This Year
  • ASRT N/A
  • ACOG N/A
  • Revenue Next Year
  • ASRT $1.84
  • ACOG N/A
  • P/E Ratio
  • ASRT N/A
  • ACOG N/A
  • Revenue Growth
  • ASRT N/A
  • ACOG N/A
  • 52 Week Low
  • ASRT $0.73
  • ACOG $4.66
  • 52 Week High
  • ASRT $1.80
  • ACOG $7.00
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 50.64
  • ACOG N/A
  • Support Level
  • ASRT $0.78
  • ACOG N/A
  • Resistance Level
  • ASRT $0.88
  • ACOG N/A
  • Average True Range (ATR)
  • ASRT 0.03
  • ACOG 0.00
  • MACD
  • ASRT 0.01
  • ACOG 0.00
  • Stochastic Oscillator
  • ASRT 61.60
  • ACOG 0.00

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.

Share on Social Networks: